4
Changes in Ownership
Cartesian Therapeutics, Inc. Filed Acc 0001638599-18-000589
Options or other derivatives
- Director acquired 95,000 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
Farokhzad Omid · Director
Table II: Derivative
1 line| Date | Transaction | Shares | Exercise | Expires | Underlying | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| 2018-05-30 | Grant or award : show line 1 in the form Stock Option (Right to Buy) | +95,000 | $12.02 | 2028-05-29 | 95,000 | 95,000 | D |
Loading xslF345X03/doc4_5435.xml…